Introduction
============

Intervertebral disc degeneration (IDD) is characterized by pathological changes in the intervertebral disc, and is associated with the development of lower back pain and acute lumbar radiculopathy ([@b1-mmr-12-04-4925]). It is widely accepted that a number of factors, such as genetic predisposition, abnormal biomechanical loading, ageing and decreased nutrient transport could result in the development of IDD ([@b2-mmr-12-04-4925],[@b3-mmr-12-04-4925]). However, the underlying mechanism associated with IDD remains largely unknown.

MicroRNAs (miRNAs) are small (19--24 nt), non-protein-coding nucleic acids that regulate specific target gene products via binding to the 3′ untranslated regions (UTRs) of mRNA transcripts, contributing to mRNA degradation or translational blockade ([@b4-mmr-12-04-4925]). To date, \>1,000 human miRNAs have been experimentally identified, and it is estimated that they regulate more than one-third of cellular mRNA and are involved in a number of diseases processes ([@b5-mmr-12-04-4925]). Emerging evidence has strongly suggested that abnormal miRNA expression is a common and important feature in IDD. For example, a study by Zhao *et al* ([@b6-mmr-12-04-4925]) identified 25 upregulated miRNAs and 26 downregulated miRNAs in the IDD via microarray analysis and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Similarly, 29 miRNAs were found to be differentially expressed in degenerative nucleus pulposus (NP), and deregulated miRNA-155 promoted Fas-mediated apoptosis through targeting caspase-3 and fas-associated death domain containing protein ([@b7-mmr-12-04-4925]). In addition, miRNA-34a induced by p53 lead to cell apoptosis resulting in the development of osteoarthritis ([@b8-mmr-12-04-4925]). In addition, a previous study demonstrated that miRNA-140 expression is associated with chondrocyte differentiation, and therefore contributes to the development of osteoarthritis ([@b9-mmr-12-04-4925]).

Since mRNA is an important intermediary agent for miRNA action, the interaction between miRNA and mRNA is important in the development of complex diseases. Therefore, the objective of this study was to comprehensively investigate the IDD-related gene regulation by constructing miRNA-target gene networks. Furthermore, their underlying molecular mechanisms were also characterized by function annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Materials and methods
=====================

Affymetrix microarray data
--------------------------

GSE 19943 ([@b7-mmr-12-04-4925]) and GSE 34095 datasets were accessible at the National Center for Biotechnology Information Gene Expression Omnibus data-base (<http://www.ncbi.nlm.nih.gov/geo/>). The miRNA and mRNA microarray datasets are based on the platforms of GPL9964-Exiqon human miRCURY LNA™ miRNA Array V11.0 (Exiqon, Vedbaek, Denmark) and GPL96-\[HG-U133A\] Affymetrix Human Genome U133A Array (Affymetrix, Santa Clara, CA, USA), respectively. miRNA expression profiling of human NP cells derived from 3 patients with disc degeneration compared with 3 controls with scoliosis. Similarly, mRNA datasets included human intervertebral disc tissues harvested from 3 elderly and 3 younger patients with degenerative disc disease and adolescent idiopathic scoliosis, respectively.

Data processing and DEG screen
------------------------------

The correlation between miRNA and the target gene was determined based on the original expression profiling, and log 2-transformed microarray data was used to screen the differentially expressed genes (DEGs) in intervertebral disc tissues from patients with degenerative disc disease and adolescent idiopathic scoliosis by Linear Models for Microarray Data (LIMMA) package in R ([@b10-mmr-12-04-4925]). False discovery rates (FDRs) were calculated using the method of Benjamini and Hochberg ([@b11-mmr-12-04-4925]). FDR-corrected P\<0.05 and \|log (fold change)\|\>1 were defined as the thresholds for screening DEGs.

Differentially expressed analysis of miRNA and the target genes
---------------------------------------------------------------

miRNA and mRNA integrated analysis (MMIA) is a versatile web server integrating miRNA and mRNA expression data with predicted miRNA target information for analyzing miRNA-associated phenotypes and biological functions by gene set analysis ([@b12-mmr-12-04-4925]). Target genes of differentially expressed miRNA were screened by combining TargetScan 5.1 (<http://www.targetscan.org>; Whitehead Institute for Biomedical Research, Cambridge, MA, USA) and Pictar4way algorithms (<http://pictar.mdc-berlin.de>; Center for Comparative Functional Genomics and the Max Delbruck Centrum, Berlin, Germany). To explore the association between miRNA and DEGs in the development of IDD, the enrolled DEGs were then further screened to analyze the miRNA and the target DEGs in human intervertebral disc tissue.

Regulation association analysis and network construction
--------------------------------------------------------

The software of Search Tool for the Retrieval of Interacting Genes (STRING; <http://string-db.org/>) is a tool that could cluster networks on demand, update on-screen previews of structural information including homology models and extensive data updates ([@b13-mmr-12-04-4925]). In order to correctly uncover and annotate all functional interactions among proteins in the human NP cells, STRING was employed to determine the correlation between the differentially expressed miRNA and DEGs in the IDD process. A confidence score was employed to define the interaction between miRNA and DEGs based on experimental measurements and computational prediction techniques. The confidence score \>0.4 was defined statistically significant. Cytoscape (<http://cytoscape.org/>) is a popular bioinformatics package for biological network visualization and data integration ([@b14-mmr-12-04-4925]). The interaction network was visualized by the Cytoscape tool based on the above association.

Function annotation and pathway analysis
----------------------------------------

The Biological Networks Gene Ontology tool (BiNGO; <http://www.psb.ugent.be/cbd/papers/BiNGO/>), as a cytoscape plugin, is an open-source Java tool to determine which Gene Ontology (GO) terms are significantly overrepresented in a set of genes ([@b15-mmr-12-04-4925]). BiNGO was used to perform functional annotation for the network with a threshold of adjusted P\<0.05 based on hypergeometric distribution. Web-based Gene Set Enrichment Analysis Toolkit (WebGestalt; <http://www.webgestalt.org>) is composed of four modules: Gene set management, information retrieval, organization/visualization and statistics, and shifted the study from \'single genes\' to \'gene sets\' ([@b16-mmr-12-04-4925],[@b17-mmr-12-04-4925]). WebGestalt was used to perform KEGG pathway analysis for DEGs regulated by differentially expressed miRNA in IDD tissue and P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Differentially expressed miRNA and mRNA analysis
------------------------------------------------

A total of 253 miRNAs and their associated 22,2215 genes were obtained based on their correlation between the miRNAs and associated genes of the original expression profile. Differentially expressed analyses of miRNA and mRNA were performed between cases and control by LIMMA package in R language and multiple comparisons using FDR and Benjamini and Hochberg after normalization ([Fig. 1](#f1-mmr-12-04-4925){ref-type="fig"}). A total of 850 DEGs and 9 miRNAs, including 3 up- and 6 downregulated miRNAs ([Table I](#tI-mmr-12-04-4925){ref-type="table"}), were identified to be significantly expressed with thresholds of \|log~2~ FC\|\>1 and FDR-corrected P\<0.05.

miRNA-target gene regulation association
----------------------------------------

Target genes of nine differentially expressed miRNAs were obtained from the TargetScan database, and the abnormally expressed miRNAs were then screened based on conservative property at the 3′UTR and context score. Among them, target genes of 8 abnormally expressed miRNAs were found to be differentially expressed. As shown in [Table I](#tI-mmr-12-04-4925){ref-type="table"}, a total of 8 miRNAs and 37 target DEGs were screened. No predicted target genes were identified for miRNA-30c-1.

miRNA-DEG regulation network construction
-----------------------------------------

To explore the regulation network for the target genes regulated by miRNAs, the correlation between proteins encoded by DEGs was identified by mapping both up- and downregulated DEGs to STRING. A total of 4 interaction pairs were constructed with a confidence score \>0.4, including interaction relationships of SMAD family member 4 (SMAD4) and activin A receptor, type IB, WW domain containing adaptor with coiled-coil and bromodomain adjacent to zinc finger domain, 1B, BMI1 polycomb ring finger oncogene and cyclin-dependent kinase inhibitor 1B (CDKN1B), SMAD4 and CDKN1B. As shown in ([Fig. 2](#f2-mmr-12-04-4925){ref-type="fig"}), the interactions were visualized by Cytoscape. The network included 8 miRNA and 37 target DEGs, including miRNA-222 targeting the gene set of ataxin 1, BMI1, CDKN1B and defective in cullin neddylation 1, domain containing 4 and miRNA-589 targeting the gene set of F-box and WD repeat domain containing 2, G-rich RNA sequence binding factor 1, protein kinase N2 and SMAD4.

Function and pathway annotation
-------------------------------

miRNAs regulate specific target gene products via hybridization to mRNA, the 8 miRNAs regulated 37 common target genes, which may be important in the development of IDD. Therefore, the present study used function annotation and pathway analysis for the DEGs regulated by the differential miRNAs in human NP cells. As shown in [Table II](#tII-mmr-12-04-4925){ref-type="table"}, the top 10 GO biological processes were identified for DEGs involved in upregulated miRNA networks, including negative regulation of cell growth, negative regulation of cell size and negative regulation of growth, and DEGs associated with downregulated miRNAs, such as positive regulation of transcription by glucose, positive regulation of transcription from the RNA polymerase II promoter by glucose and positive of transcription from RNA polymerase II promoter by carbon catabolites, based on the hypergeometric test and P\<0.05 ([Table II](#tII-mmr-12-04-4925){ref-type="table"}). Two KEGG pathways were screened using the WebGestalt tool according to adjusted P\<0.05, the cell cycle and pathways in cancer ([Table III](#tIII-mmr-12-04-4925){ref-type="table"}). Notably, the two pathways involved CDKN1B and SMAD4.

Discussion
==========

In an effort to gain greater understanding of the mechanism underlying IDD, miRNA and mRNA datasets were down-loaded to explore the IDD-related genes and an miRNA regulation network was constructed to investigate the potential mechanism in the development of IDD. Functional annotation showed that the upregulated miRNA predominantly regulated pathways associated with cell activity, such as the negative regulation of cell growth, cell size and cell death, and downregulated miRNAs predominantly regulated pathways associated with the regulation of transcription by glucose and the regulation of transcription by carbon catabolites. In the present study, the differentially expressed miRNAs were predicted to control 2 pathways relevant to IDD, including the cell cycle and pathways in cancer. Notably, the pathways were regulated by CDKN1B and SMAD4 genes. Furthermore, CDKN1B and SMAD4 were shown to exhibit a significant interaction and were regulated by miRNA-222 and miRNA-589, respectively.

The disc is composed of the central highly hydrated NP, the surrounding elastic and fibrous annulus fibrosus (AF), and the cartilaginous endplate (CEP), and each of these tissues has a different function and consists of a specific matrix structure that is maintained by a cell population with a distinct phenotype. Disturbed homeostasis of these tissues may lead to pathological conditions, including pathologies associated with cellular phenotype and biochemical factors ([@b18-mmr-12-04-4925]). In accordance with the study by Wang *et al* ([@b7-mmr-12-04-4925]), Fas-mediated apoptosis in human IDD triggered by miRNA-155 via targeting Fas-associated death domain containing protein and caspase-3 contributes to IDD. In the current study, the upregulated miRNA predominantly regulated pathways associated with cell activity, such as the negative regulation of cell growth, cell size and cell death. Moreover, the critical roles of type II collagen and proteoglycan (predominantly aggrecan) were demonstrated to be important for proper disc function, particularly in the nucleus pulposus ([@b19-mmr-12-04-4925]). A previous study also demonstrated that significant changes in the extracellular matrix occur in the development of IDD ([@b20-mmr-12-04-4925]). Consistent with the above research, our results suggest that downregulated miRNAs predominantly regulate pathways associated with the regulation of transcription by glucose and regulation of transcription by carbon catabolites.

In the current study, miRNA-222 levels were found to be upregulated in the IDD tissue and CDNK1B is one of the important target gene sets. A previous study demonstrated that miRNA-222 could directly target the 3′-UTR of CDKN1B and CDKN1C mRNAs to reduce CDN1B and CDN1C protein levels ([@b21-mmr-12-04-4925]). The CDKN1B gene is a member of the Cip/Kip family of cyclin-dependent kinase (CDK) inhibitors that function to negatively control cell cycle progression ([@b22-mmr-12-04-4925]), and coordinate competency for initiation of S phase with growth factor signaling pathways stimulating cell proliferation. In addition, deregulated miR-221 and miR-222 promote cancerous growth by modulating the expression of CDKN1B ([@b23-mmr-12-04-4925]). The disturbed homeostasis induced by cell proliferation may contribute to the development and occurrence of IDD. Therefore, miRNA-222 may be a crucial element for IDD progression by inhibiting cell proliferation or pathways in cancer via targeting CDKN1B.

miRNA-589 levels are upregulated in the IDD tissue and the miRNA targeted SMAD4 in this study. It has been demonstrated that miRNA-589 mediates transforming growth factor (TGF)-β induced epithelial mesenchymal transition in human peritoneal mesothelial cell, and epithelial mesenchymal transition is a key factor for the development and progression of peritoneal fibrosis ([@b24-mmr-12-04-4925]). TGF-β, as an important proinflammatory factor, could promote the expression of catabolic genes and suppress the expression of critical extracellular matrix genes by the NP cells and AF cells in intervertebral disc tissue ([@b25-mmr-12-04-4925]). Notably, SMAD4 is also a coactivator and mediator of signal transduction by TGF-β, which encodes a member of the Smad family of signal transduction proteins. Therefore, these results suggest that SMAD4 may be synergistic with TGF-β, and miRNA-589 may influence the extracellular matrix by targeting SMAD4. Although no experimental evidence has demonstrated that miRNA-589 targets SMAD4 in NP cells, the results of the present study provides further clarification.

In conclusion, the present study has provided novel information regarding the regulation network of IDD. The overexpression of miRNA-222 may be associated with IDD progression by inhibiting cell proliferation or pathways in cancer via targeting CDKN1B. Overexpression of miRNA-589 represses SMAD4 and influences the extracellular matrix via intracellular TGF-β signal transduction. However, further studies are required to confirm the role of these miRNAs and target genes.

![Box plots for miRNA and mRNA microarray datasets after normalization. (A) Box plot for miRNA microarray dataset after normalization; (B) box plot for mRNA microarray dataset after normalization. miRNA, microRNA.](MMR-12-04-4925-g00){#f1-mmr-12-04-4925}
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###### 

Differentially expressed miRNAs in intervertebral disc degeneration tissue and the target genes.

  miRNA_ID_LIST      ID     FDR      logFC    Target genes
  ------------------ ------ -------- -------- ------------------------------------
  hsa-miR-30c-1^a^   1158   0.0315   −3.01    --
  hsa-miR-638        1151   0.0483   −2.254   PAK2
  hsa-miR-1275       1223   0.0387   −2.252   SERBP1, BAIAP2, USF2
  hsa-miR-589        1104   0.0407   2.5      FBXW2, GRSF1, PKN2, SMAD4
  hsa-miR-1286       1026   0.0387   2.767    ABCF2, BACH2, BAZ1B, CELSR2,
                                              SYP, VAMP1
  hsa-miR-222        1012   0.0315   3.05     ATXN1, BMI1, CDKN1B, DCUN1D4,
                                              GTF2E1, KIAA0368, NAP1L1, NFYB,
                                              PAIP1, T1MP3, TRAM2
  hsa-miR-220b       1122   0.0387   4.216    ACVR1B, ARL4C, FAM20B, SMYD5
  hsa-miR-640        1030   0.0132   4.559    GRIK2, TNP01
  hsa-miR-532-3p     1060   0.0315   4.755    FOXJ3, LBH, PBX2, PI4KB, UBL3, WAC

miRNA, microRNA; FDR, false discovery rate.

###### 

Gene functional annotation for up- and downregulated miRNA-target genes networks.

  A, Upregulated miRNA network                                                                                                    
  ------------------------------ ---------- ------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------
  30308                          0.044851   Negative regulation of cell growth                                                    ACVR1B, CDKN1B, SMAD4
  45792                          0.044851   Negative regulation of cell size                                                      ACVR1B, CDKN1B, SMAD4
  45926                          0.044851   Negative regulation of growth                                                         ACVR1B, CDKN1B, SMAD4
  12502                          0.046347   Induction of programmed cell death                                                    ACVR1B, CDKN1B, GRIK2, TIMP3
  60255                          0.046347   Regulation of macromolecule metabolic process                                         BMI1, BACH2, PAIP1, SMAD4, NFYB, CELSR2, FOXJ3, ATXN1, GTF2E1, ACVR1B, LBH, CDKN1B, BAZ1B, PBX2
  31323                          0.046347   Regulation of cellular metabolic process                                              BMI1, BACH2, PAIP1, SMAD4, NFYB, CELSR2, FOXJ3, ATXN1, GTF2E1, ACVR1B, LBH, CDKN1B, BAZ1B, PBX2
  19219                          0.046347   Regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process   BMI1, BACH2, PAIP1, SMAD4, NFYB, CELSR2, FOXJ3, ATXN1, GTF2E1, ACVR1B, LBH, BAZ1B, PBX2
  19222                          0.046347   Regulation of metabolic process                                                       BMI1, BACH2, PAIP1, SMAD4, NFYB, CELSR2, FOXJ3, ATXN1, GTF2E1, ACVR1B, LBH, CDKN1B, BAZ1B, PBX2
  10556                          0.046347   Regulation of macromolecule                                                           BMI1, BACH2, PAIP1, SMAD4, NFYB, CELSR2, FOXJ3, ATXN1, GTF2E1, ACVR1B, LBH, BAZ1B, PBX2
  8361                           0.046347   Regulation of cell size                                                               ACVR1B, CDKN1B, SMAD4

  B, Downregulated miRNA network                                                                                                           
  -------------------------------- ---------- -------------------------------------------------------------------------------------------- --------
  46016                            0.011654   Positive regulation of transcription by glucose                                              USF2
  432                              0.011654   Positive regulation of transcription from RNA polymerase II promoter by glucose              USF2
  436                              0.011654   Positive regulation of transcription from RNA polymerase II promoter by carbon catabolites   USF2
  429                              0.011654   Regulation of transcription from RNA polymerase II promoter by carbon catabolites            USF2
  430                              0.011654   Regulation of transcription from RNA polymerase II promoter by glucose                       USF2
  45991                            0.011654   Positive regulation of transcription by carbon catabolites                                   USF2
  46015                            0.01311    Regulation of transcription by glucose                                                       USF2
  45990                            0.01311    Regulation of transcription by carbon catabolites                                            USF2
  43488                            0.017476   Regulation of mRNA stability                                                                 SERBP1
  31670                            0.017476   Cellular response to nutrient                                                                USF2

miRNA, microRNA; GO, gene ontology.

###### 

Kyoto encyclopedia of genes and genomes pathways for differentially expressed genes regulated by miRNAs.

  Pathway              Adj P-value   Gene sets
  -------------------- ------------- ---------------
  Cell cycle           0.0062        CDKN1B, SMAD4
  Pathways in cancer   0.0258        CDKN1B, SMAD4
